Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-29 @ 10:12 PM
Study NCT ID:
NCT03208556
Status:
UNKNOWN
Last Update Posted:
2017-09-14
First Post:
2017-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-27
First Submit QC Date:
None
Study First Post Date:
2017-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-12
Last Update Post Date:
2017-09-14
Last Update Post Date Type:
ACTUAL